4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-014838
President and CEO sold 33,033 shares at $3.03 ($100,064)
- President and CEO acquired 252,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Paulson Richard A. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-28 | Grant or award : show line 1 in the form | +252,000 | 856,655 | D | ||
| 2023-03-01 | Sale : show line 2 in the form | −33,033 | $3.03 | $100,064 | 823,622 | D |
| Open-market sales · 33,033 sh · avg $3.03 · $100,064 | ||||||
Loading xslF345X03/doc4.xml…